We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




CACLP 2025 New Date and Venue Announced

By LabMedica International staff writers
Posted on 16 Oct 2024

The 22nd China International In Vitro Diagnostic Expo, organized by the China Association of Clinical Laboratory Practice Expo (CACLP, Shanghai, China), is set to take place from March 21 to 24, 2025, in Hangzhou, China. More...

Following the impressive numbers recorded by CACLP 2024, the upcoming event will return to provide global participants with a convenient and enriching experience at the newly inaugurated Hangzhou Grand Convention & Exhibition Center.

Situated in the economically dynamic Yangtze River Delta, Hangzhou boasts convenient transportation, advanced innovation, and a wealth of natural and cultural resources. This charming city creates an ideal environment for the in vitro diagnostic (IVD) industry. Hangzhou has 6,626 medical and healthcare institutions, which include 414 hospitals and 27 top-tier (Grade A, Level 3) hospitals. Moreover, Hangzhou has established China’s first dedicated IVD industry promotion institute to support local industry development. With China’s favorable visa-free policy, international participants will find it easier than ever to attend and explore an optimal setting for collaboration, networking, and the latest market trends and innovations.

CACLP 2024 was a remarkable success, showcasing a wide range of products and technologies from participants. The event, which took place in March 2024, attracted 1,346 exhibitors and 42,751 visitors from China and 40 other countries, all gathered in a vast area of 130,000 square meters. A series of academic activities featured 125 scientific lectures presented by 315 academic speakers, drawing over 5,000 delegates. These activities received 462,150 online views via CACLP's WeChat channels and app.

Following the success of CACLP 2024, numerous professionals across the IVD industry are expected to participate in the concurrent academic activities during CACLP 2025. These include the 10th China Experimental Medicine Conference (CEMC) and series sessions, as well as the 12th China IVD Industry Development Conference (CIIDC) and series forums. These activities will encompass in-depth discussions on current hot topics in laboratory medicine and IVD, with renowned experts and scholars presenting cutting-edge research findings, while industry leaders share valuable experiences.

Related Links:
CACLP


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
All-in-One Molecular System
AIO M160
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.